PRTA Q2 2024 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$132M+3184.7% YoY

Gross Profit

$132M100.0% margin

Operating Income

$58M44.2% margin

Net Income

$67M50.7% margin

EPS (Diluted)

$1.22

QoQ Revenue Growth

+263928.0%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$16M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$646M

Total Liabilities

$64M

Stockholders' Equity

$582M

Cash & Equivalents

$564M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$132M	$4M	+3184.7%
Gross Profit	$132M	-$52M	+353.9%
Operating Income	$58M	-$67M	+187.8%
Net Income	$67M	-$55M	+222.5%

Revenue Segments

Collaboration

$132M100%